Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

USPTO appoints new acting commissioner for patents
Careers
The ex-Greenberg Traurig shareholder will oversee the office’s 14,000-strong patent division, as the agency prepares for the departure of deputy director Coke Morgan Stewart.   31 July 2026
European court strikes down hearing aid sensor patent
MedTech
A dispute over optical sensor technology in miniature hearing devices ended with the EPO revoking a patent, finding the invention obvious despite ruling it was new over the closest prior art.   30 July 2026
Fish & Richardson adds AI and medical device specialist
Careers
The engineer-turned-lawyer joins as a principal, bringing 15 years of experience advising on patent strategy across AI, software, and medical devices.   29 July 2026
MedTech
Years of litigation over biodegradable drug-delivery technology took another turn after the Federal Circuit delivered a significant win for the medical device maker.   28 July 2026
Careers
The firm has added partners with expertise in life sciences, technology disputes and trademark strategy, alongside leadership changes at its Hong Kong affiliate.   27 July 2026
MedTech
The latest clash between two facial aesthetics rivals centres on a Swiss rival’s newly approved syringe, which AbbVie and Allergan claim infringes five US design patents.   23 July 2026
Regulation & Industry
Plans to merge the UK’s standalone science ministry into an expanded business department, coupled with the departure of the Science Minister, mark a change in the country’s approach to science and innovation.   22 July 2026
Biotech
A Munich court ruled that Illumina infringed a rival’s DNA sequencing patents, handing the challenger an early victory in a dispute that is playing out across Europe and the US.   16 July 2026
Careers
A high-profile hire will co-chair the firm's new office, bringing experience across biotech, therapeutics, genomics, diagnostics, and medical devices.   16 July 2026
Biotech
French drugmaker's Translate Bio unit accuses COVID rivals of infringing core lipid nanoparticle and mRNA purification patents, seeking damages from vaccines worth billions.   15 July 2026

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.